Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 ...

We will discover new tools, new ways that we can help species that are still alive but in danger of becoming extinct.” ...

Even when the University organizes a new big research center, the complicated task of cloning a mammoth cannot be solved without support from partners. "Doing complicated studies on our own is ...

Colossal Biosciences plans to revive the woolly mammoth using gene editing. But is de-extinction a breakthrough or a costly spectacle?

Cloning the mammoth is impossible. What is left of the giant mammal is found in fragments, echoes of the past. Instead of a complete replica, Colossal aims to piece together DNA from other animals ...

has raised $435 million to “de-extinct” the woolly mammoth, a species that hasn’t walked the Earth in over 4,000 years. The company also plans to clone a dodo bird and a Tasmanian tiger.

The biotech company Colossal Biosciences has long aspired to bring back the extinct woolly mammoth, which roamed the Northern Hemisphere thousands of years ago, during the last ice age. But for now, ...

The mice were created by Colossal Biosciences, which edits DNA for species conservation, and has been working to bring back the woolly mammoth since 2021.

Talk of cloning surged again a few weeks later when a group at Pennsylvania State University, led by Webb Miller and Stephan C. Schuster, published 70 percent of the mammoth genome, laying out ...

According to Live Science, the hunter was exploring the O2 Ranch in Brewster and Presidio counties near Big Bend National Park when he spotted a mammoth tusk lying in the drainage area of a creek bed.